Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.66
+0.20 (3.10%)
Aug 18, 2026, 12:21 PM EDT - Market open
Journey Medical Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Journey Medical stock has a consensus rating of "Strong Buy" and an average price target of $13.75. The average 1-year stock price forecast is 106.46% higher than the current stock price, while the lowest is $13 (+95.20%) and the highest is $15 (+125.23%).
Price Target: $13.75 (+106.46%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Journey Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $16 → $14 | Buy | Maintains | $16 → $14 | +110.21% | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +95.20% | Aug 13, 2026 |
| Lake Street | Lake Street | Buy Maintains $13 | Buy | Maintains | $13 | +95.20% | May 14, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +80.18% | Mar 26, 2026 |
Financial Forecast
Revenue This Year
81.38M
from 61.86M
Increased by 31.55%
Revenue Next Year
130.43M
from 81.38M
Increased by 60.28%
EPS This Year
n/a
EPS Next Year
n/a